Concerta is the most widely prescribed extended-release formulation of methylphenidate, a central nervous system stimulant that has been a cornerstone treatment for attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults since the early 2000s. Unlike immediate-release methylphenidate tablets that require multiple daily doses, Concerta uses a sophisticated osmotic-controlled release oral delivery system (OROS) […]
Concerta is the brand name for an extended-release formulation of methylphenidate, a central nervous system stimulant widely prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and, in some cases, narcolepsy. Approved by regulatory agencies including the FDA, EMA, Health Canada, MHRA, and TGA, Concerta utilizes an advanced osmotic-controlled release oral delivery system (OROS) […]